Mobile

Study to Demonstrate Equivalence of Formoterol 12 and 24 µg Delivered Via Two Types of Single Dose Dry Powder Inhalers (Concept1 and Aerolizer)

Mise à jour : Il y a 5 ans
Référence : NCT00443482

Femme et Homme

  • | Pays :
  • Germany
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

This study is designed to demonstrate that formoterol 12µg and 24µg delivered by a new inhalation device (Concept1) are equivalent to the corresponding dose of formoterol delivered by the Aerolizer device in terms of efficacy, in patients with persistent asthma.

Critère d'inclusion

  • Asthma

Liens